Seelos Therapeutics (NASDAQ:SEEL) just reported results for the fourth quarter of 2023.
- Seelos Therapeutics reported earnings per share of -79 cents. This was above the analyst estimate for EPS of -80 cents.
- The company reported revenue of $653,000.
Source: iQoncept / Shutterstock
Seelos Therapeutics (NASDAQ:SEEL) just reported results for the fourth quarter of 2023.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/seel-stock-earnings-seelos-therapeutics-for-q4-of-2023/.
©2025 InvestorPlace Media, LLC